1XUT image
Entry Detail
PDB ID:
1XUT
Title:
Solution structure of TACI-CRD2
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2004-10-26
Release Date:
2004-11-09
Method Details:
Experimental Method:
Conformers Calculated:
100
Conformers Submitted:
20
Selection Criteria:
structures with the least restraint violations
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Tumor necrosis factor receptor superfamily member 13B
Chain IDs:A
Chain Length:46
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.
J.Biol.Chem. 280 7218 7227 (2005)
PMID: 15542592 DOI: 10.1074/jbc.M411714200

Abstact

TACI is a member of the tumor necrosis factor receptor superfamily and serves as a key regulator of B cell function. TACI binds two ligands, APRIL and BAFF, with high affinity and contains two cysteine-rich domains (CRDs) in its extracellular region; in contrast, BCMA and BR3, the other known high affinity receptors for APRIL and BAFF, respectively, contain only a single or partial CRD. However, another form of TACI exists wherein the N-terminal CRD is removed by alternative splicing. We find that this shorter form is capable of ligand-induced cell signaling and that the second CRD alone (TACI_d2) contains full affinity for both ligands. Furthermore, we report the solution structure and alanine-scanning mutagenesis of TACI_d2 along with co-crystal structures of APRIL.TACI_d2 and APRIL.BCMA complexes that together reveal the mechanism by which TACI engages high affinity ligand binding through a single CRD, and we highlight sources of ligand-receptor specificity within the APRIL/BAFF system.

Legend

Protein

Chemical

Disease

Primary Citation of related structures